Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
DLX
|
Michael S Mathews
SVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 224 Reduced 1.44% |
$6,803
$30.37 p/Share
|
Mar 01
2022 |
DLX
|
Michael S Mathews
SVP, Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 454 Added 2.84% |
-
|
Mar 01
2022 |
DLX
|
Barry C Mc Carthy
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,981 Reduced 3.51% |
$90,533
$30.37 p/Share
|
Mar 01
2022 |
DLX
|
Barry C Mc Carthy
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 6,058 Added 6.65% |
-
|
Mar 01
2022 |
DLX
|
Amanda B Parrilli
SVP, Chief of Strategy |
SELL
Payment of exercise price or tax liability
|
Direct | 206 Reduced 6.88% |
$6,256
$30.37 p/Share
|
Mar 01
2022 |
DLX
|
Amanda B Parrilli
SVP, Chief of Strategy |
BUY
Exercise of conversion of derivative security
|
Direct | 454 Added 13.16% |
-
|
Mar 01
2022 |
DLX
|
Michael Aaron Reed
SVP, Division President |
SELL
Payment of exercise price or tax liability
|
Direct | 390 Reduced 8.58% |
$11,844
$30.37 p/Share
|
Mar 01
2022 |
DLX
|
Michael Aaron Reed
SVP, Division President |
BUY
Exercise of conversion of derivative security
|
Direct | 833 Added 15.49% |
-
|
Mar 01
2022 |
DLX
|
Thomas Riccio
SVP, Division President |
SELL
Payment of exercise price or tax liability
|
Direct | 367 Reduced 16.25% |
$11,146
$30.37 p/Share
|
Mar 01
2022 |
DLX
|
Thomas Riccio
SVP, Division President |
BUY
Exercise of conversion of derivative security
|
Direct | 757 Added 25.1% |
-
|
Mar 01
2022 |
DLX
|
Christopher Lee Thomas
SVP, Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 676 Reduced 3.96% |
$20,530
$30.37 p/Share
|
Mar 01
2022 |
DLX
|
Christopher Lee Thomas
SVP, Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,082 Added 10.88% |
-
|
Mar 01
2022 |
DLX
|
Ronald Van Houwelingen
VP, Controller, PAO |
SELL
Payment of exercise price or tax liability
|
Direct | 381 Reduced 7.87% |
$11,571
$30.37 p/Share
|
Mar 01
2022 |
DLX
|
Ronald Van Houwelingen
VP, Controller, PAO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,060 Added 17.95% |
-
|
Mar 01
2022 |
OSCR
|
Richard Scott Blackley
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,016 Added 3.84% |
-
|
Mar 01
2022 |
OSCR
|
Alessandrea C. Quane
EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,016 Added 7.26% |
-
|
Mar 01
2022 |
OSCR
|
Meghan V. Joyce
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,016 Added 13.33% |
-
|
Mar 01
2022 |
OSCR
|
Dennis Weaver
Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,171 Added 28.8% |
-
|
Mar 01
2022 |
ENTA
|
Nathalie Adda
Sr. VP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 24,339 Reduced 41.03% |
$1,719,794
$70.66 p/Share
|
Mar 01
2022 |
ENTA
|
Nathalie Adda
Sr. VP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 24,339 Added 29.09% |
$1,057,773
$43.46 p/Share
|
Mar 01
2022 |
PAR
|
Savneet Singh
CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct | 20,887 Reduced 9.47% |
$864,513
$41.39 p/Share
|
Mar 01
2022 |
PAR
|
Savneet Singh
CEO & President |
BUY
Grant, award, or other acquisition
|
Direct | 40,969 Added 15.66% |
-
|
Mar 01
2022 |
PAR
|
Raju Malhotra
CHF PRODUCT & TECH OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 202 Reduced 12.8% |
$8,361
$41.39 p/Share
|
Mar 01
2022 |
NEO
|
Gina M Wallar
President, Pharma Services |
BUY
Grant, award, or other acquisition
|
Direct | 11,677 Added 25.88% |
-
|
Mar 01
2022 |
NEO
|
Douglas Matthew Brown
Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct | 35,030 Added 31.2% |
-
|
Mar 01
2022 |
NEO
|
William Bonello
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 397 Reduced 0.39% |
-
|
Mar 01
2022 |
NEO
|
William Bonello
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 40,869 Added 28.46% |
-
|
Mar 01
2022 |
NEO
|
George Cardoza
President & COO, Lab Ops |
SELL
Payment of exercise price or tax liability
|
Direct | 503 Reduced 0.2% |
-
|
Mar 01
2022 |
NEO
|
Cynthia J Dieter
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,341 Added 33.22% |
-
|
Mar 01
2022 |
NEO
|
Mark Mallon
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 142,457 Added 27.9% |
-
|
Mar 01
2022 |
NEO
|
Halley E Gilbert
Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 42,036 Added 22.19% |
-
|
Mar 01
2022 |
INSW
|
Jeffrey Pribor
SVP and CFO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.55% |
$18,450
$18.45 p/Share
|
Mar 01
2022 |
SSP
|
Adam Symson
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 76,810 Reduced 24.12% |
$1,707,486
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Adam Symson
President and CEO |
BUY
Conversion of derivative security
|
Direct | 167,177 Added 34.42% |
$3,716,345
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
William Appleton |
SELL
Payment of exercise price or tax liability
|
Direct | 15,205 Reduced 12.54% |
$338,007
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
William Appleton |
BUY
Conversion of derivative security
|
Direct | 35,536 Added 22.66% |
$789,965
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Jason Combs
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,553 Reduced 32.49% |
$123,443
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Jason Combs
Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct | 12,378 Added 42.0% |
$275,163
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Douglas F Lyons
SVP, Fin. Strat.& Special Proj |
SELL
Payment of exercise price or tax liability
|
Direct | 7,924 Reduced 43.3% |
$176,151
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Douglas F Lyons
SVP, Fin. Strat.& Special Proj |
BUY
Conversion of derivative security
|
Direct | 18,299 Added 50.0% |
$406,787
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Carolyn Pione Micheli
SVP, Corp. Communications & IR |
SELL
Payment of exercise price or tax liability
|
Direct | 5,065 Reduced 14.92% |
$112,595
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Carolyn Pione Micheli
SVP, Corp. Communications & IR |
BUY
Conversion of derivative security
|
Direct | 10,525 Added 23.66% |
$233,971
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Daniel Perschke
SVP, Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 1,829 Reduced 22.54% |
$40,659
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Daniel Perschke
SVP, Controller |
BUY
Conversion of derivative security
|
Direct | 4,887 Added 37.59% |
$108,638
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Rebecca A. Riegelsberger
Treasurer, Vice President, Tax |
SELL
Payment of exercise price or tax liability
|
Direct | 2,557 Reduced 20.73% |
$56,842
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Rebecca A. Riegelsberger
Treasurer, Vice President, Tax |
BUY
Conversion of derivative security
|
Direct | 5,017 Added 28.91% |
$111,528
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Laura Tomlin
Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 11,451 Reduced 34.53% |
$254,556
$22.23 p/Share
|
Mar 01
2022 |
SSP
|
Laura Tomlin
Chief Transformation Officer |
BUY
Conversion of derivative security
|
Direct | 24,401 Added 42.39% |
$542,434
$22.23 p/Share
|
Mar 01
2022 |
FGEN
|
Mark Eisner
EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 756 Reduced 0.48% |
$10,297
$13.62 p/Share
|
Mar 01
2022 |
KYMR
|
Elaine Caughey
Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,000 Added 50.0% |
-
|
Mar 01
2022 |